Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
To evaluate the effect of agalsidase beta on longitudinal health-related quality of life in patients with Fabry disease.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Endodontics |
Vol/bind | 12 |
Udgave nummer | 11 |
Sider (fra-til) | 703-12 |
Antal sider | 10 |
ISSN | 0099-2399 |
DOI | |
Status | Udgivet - 1 nov. 2010 |
ID: 34197994